drugset / Trial / NCT00771433

G-CSF in Preventing Neutropenia in Women Receiving Chemotherapy for Breast Cancer

NCT00771433

Phase 2 Completed 120 enrolled Centre Francois Baclesse
Non-randomizedSupportive care

Summary

RATIONALE: G-CSF may prevent or reduce febrile neutropenia in women receiving chemotherapy for breast cancer. It is not yet known which G-CSF regimen is more effective in preventing neutropenia. PURPOSE: This phase II trial is studying how well G-CSF works in preventing neutropenia in women receiving chemotherapy for breast cancer.

Timeline

Start
2007-10
Primary completion
2011-05
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject filgrastim Protein / enzyme biologic Subcutaneous